S-100B and neuron specific enolase in outcome prediction of severe head injury

Chinese Journal of Traumatology - English Edition

Volumn 7, Issue 3, 2004, Pages 156-158

  Li, Ning ^a   Shen, Jian Kang ^a   Zhao, Wei Guo ^a   Cai, Yu ^a   Li, Yun Feng ^a   Zhan, Shin Kun ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Craniocerebral trauma; Phosphopyruvate hydratase; S 100B; Treatment outcome

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN S100B;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; HEAD INJURY; HUMAN; MALE; OUTCOMES RESEARCH; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; VALIDATION PROCESS;

EID: 2942744819     PISSN: 10081275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Raabe A, Grolms C, Keller M, et al. Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir (Wien) 1998; 140:789-791.
2. Herrmann M, Jost S, Kutz S, et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma 2000;17:113-122.
3. Qureshi AI. Evaluation of brain injury using a blood test: is there a role in clinical practice? Crit Care Med. 2002; 30:2778-2779.
4. Raabe A, Seifert V. Protein S-100B as a serum marker of brain damage in severe head injury: preliminary results. Neurosurg Rev. 2000;23:136-138.
5. Herrmann M, Curio N, Jost S, et al. Release of biochemical markers of damage to neuronal and glial brain t issue is associated with short and long term neuropsychological outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry 2001;70:95-100.
6. Raabe A, Grolms C, Seifert V. Serum markers of brain damage and outcome prediction in patients after severe head injury. Br J Neurosurg 1999;13:56-59.
7. Raabe A, Grolms C, Sorge O, et al. Serum S-100B protein in severe head injury. Neurosurgery 1999;45:477-483.
8. Woertgen C, Rothoerl RD. Serum S-100B protein in severe head injury. Neurosurgery 2000;46:1026-1027.
9. Mussack T, Biberthaler P, Kanz KG, et al. Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe head injury. Crit Care Med 2002;30:2669-2674.
10. Woertgen C, Rothoerl RD, Metz C, et al. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma 1999;47:1126-1130.
11. Rothoerl RD, Woertgen C, Brawanski A. S-100B serum levels and outcome after severe head injury. Acta Neurochir Suppl 2000;76:97-100.
12. Woertgen C, Rothoerl RD, Brawanski A. Early S-100B serum level correlates to quality of life in patients after severe head injury. Brain Inj 2002;16:807-816.
13. Rothoerl RD, Brawanski A, Woertgen C. S-100B protein serum levels after controlled cortical impact injury in the rat. Acta Neurochir (Wien) 2000;142:199-203.
14. Woertgen C, Rothoerl RD, Wiesmann M, et al. Glial and neuron serum markers after controlled cortical impact injury in the rat. Acta Neurochir Suppl 2002;81:205-207.
15. Ruchan E, Ugur B, Gokhan A, et al. Prognosis value of serum neuron specific enolase level after head injury. Neurol Res 1998;20:418-420.
16. Yoshimori Y, Kenzoh Y, Seiji M, et al. Diagnostic significance of serum neuron specific enolase and myelin basic protein assay in patients with severe head injury. Surg Neurol 1995;43:267-271.